Clinical Trials Directory

Trials / Completed

CompletedNCT05187364

BioWare for AUD and PTSD

BioWare to Enhance Treatment for Alcohol Use Disorder and Posttraumatic Stress Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study examines the ability of an innovative telehealth technology system to enhance Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) talk-therapy for individuals with posttraumatic stress disorder (PTSD) and alcohol use disorder.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCOPEThe COPE therapy is a talk-therapy in which individuals are asked about their trauma, alcohol use, mood, and behavior. The therapy occurs over 12 sessions and will be paired with a telehealth technology system to determine if it enhances the COPE therapy. The telehealth system is worn on the arm and hand during the out-of-office COPE homework assignments. It consists of a small camera (about the size of a pencil eraser), Bluetooth earpiece with microphone, monitors to measure and record heart rate and skin conductance, and a breathalyzer to assess blood alcohol content. The device will connect to an application on password protected cell phone that will monitor and record the above listed information as well as reported subjective units of distress and craving. A study coach will virtually guide participants through one out-of-office assignment per week using this technology. Interviews and surveys will be collected at study baseline and weekly during treatment.

Timeline

Start date
2022-05-05
Primary completion
2023-02-20
Completion
2023-02-20
First posted
2022-01-11
Last updated
2024-09-24
Results posted
2024-09-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05187364. Inclusion in this directory is not an endorsement.